Background: Zinc (Zn) and selenium (Se) act as trace elements essential for neuronal health, and deficiencies in either are linked to mood disorders. Both Zn and Sodium selenate (Na₂SeO₄) have shown emerging potential as antidepressant or mood-modulating agents, primarily through their neuroprotective, antioxidant, and neurochemical regulatory roles. The purpose of the current study was to examine the antidepressant properties of sodium selenate and zinc in albino rats. Here, we investigated the percentage of oxidative and antioxidant, monoamine, and monoamine oxidase (MAO) activities in the rat brain in order to grasp the likely mechanism of zinc and sodium selenate's antidepressant-like action in the tail suspension test (TST) and forced swimming test (FST). Methodology: The antidepressant activity of the mentioned substances was analyzed using modified TST and FST. Na₂SeO₄ (0.4 mg/kg ip), zinc chloride (ZnCl₂) (20 mg/kg ip), and a combination of ZnCl₂ and Na₂SeO₄ were chosen for testing over 14 days. Intraperitoneal administration of imipramine (15 mg/kg) was used as the standard reference antidepressant. Results and Discussion: In comparison to the control group, concurrent administration of ZnCl₂ and Na₂SeO₄ in the current study resulted in a significant decrease in immobility time and an increase in swimming behavior, suggesting a strong antidepressant-like effect. The possible mechanism for this activity may involve modulation of central monoaminergic neurotransmission, evidenced by a probable elevation in monoamine levels within prominent regions such as the hippocampus, cortex, striatum, and hypothalamus. Conclusion: These findings suggest that the combined administration of ZnCl₂ and Na₂SeO₄ may exhibit antidepressant-like effects, highlighting their potential utility as adjunctive agents in the management of depressive disorders.